Green Tea Extract in Preventing Cervical Cancer in Patients With Human Papillomavirus and Low-Grade Cervical Intraepithelial Neoplasia

Clinical trial NCT00303823 · COMPLETED

Trial details

NCT number: NCT00303823
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cervical Cancer Cervical Intraepithelial Neoplasia Grade 1 Human Papilloma Virus Infection

Start date: 2005-09-01
Primary completion: 2010-11-01
Enrollment: 98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.